Alpha Cognition (ACOG) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Alpha Cognition (ACOG) has outperformed Yarrow Bioscience (YARW) over the past year, gaining 19.4% versus a loss of 4.6%. Alpha Cognition is the larger company by market cap ($196.9 million vs $183.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACOG | YARW |
|---|---|---|
| Share price | $9.04 | $19.71 |
| Market cap | $196.87M | $183.39M |
| 1-day change | 0.00% | -0.81% |
| YTD return | +39.08% | -32.03% |
| 1-year return | +19.42% | -4.55% |
| 5-year return | — | -98.20% |
| EPS (TTM) | $-1.32 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.14 | $46.95 |
| 52-week low | $4.50 | $16.05 |
| Distance from 52-week high | -10.85% | -58.02% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +99.12% | +189.19% |
| Average volume | 125.15K | 86.49K |
| Shares outstanding | 21.78M | 9.30M |
| Employees | 71 | 7 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACOG has outperformed YARW by 24.0 percentage points over the past year.
- The two companies sit in different sectors: Alpha Cognition in Healthcare and Yarrow Bioscience in Health Care.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
ACOG vs YARW FAQ
Which is bigger, Alpha Cognition or Yarrow Bioscience?
Alpha Cognition (ACOG) is larger, with a market capitalization of $196.87M compared with $183.39M for Yarrow Bioscience (YARW).
Which stock has performed better over the past year, ACOG or YARW?
ACOG returned +19.42% over the past 12 months, compared with -4.55% for YARW (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Cognition and Yarrow Bioscience in the same industry?
No. Alpha Cognition is in the Healthcare sector, while Yarrow Bioscience is in Health Care.